Stability | Adaptability | Stability and Adaptability | ||||||
Ranking | Genotype | HMGV | Genotype | RPGV | RPGV*GY | Genotype | HMRPGV | HMRPGV*GY |
1 | FORMULA TL® | 8.77 | FORMULA TL® | 1.47 | 10.43 | FORMULA TL® | 1.38 | 9.82 |
2 | AS1656PRO® | 7.47 | P30F53Hx® | 1.23 | 8.73 | AS1656PRO® | 1.14 | 8.12 |
3 | P30F53Hx® | 7.32 | AS1656PRO® | 1.19 | 8.45 | P30F53Hx® | 1.11 | 7.91 |
4 | 30F53 | 7.18 | 30F53 | 1.18 | 8.37 | LG6304YG® | 1.01 | 7.19 |
5 | LG6304YG® | 6.19 | LG6304YG® | 1.08 | 7.66 | 30F53 | 1.00 | 7.08 |
6 | DKB245PRO® | 5.79 | CELERON TL® | 1.01 | 7.19 | IMPACTP VIP3® | 0.87 | 6.15 |
7 | 2A106 | 5.67 | DKB245PRO® | 0.99 | 7.01 | CELERON TL® | 0.86 | 6.08 |
8 | IMPACTP VIP3® | 5.24 | IMPACTP VIP3® | 0.97 | 6.87 | P2530 | 0.82 | 5.80 |
9 | CELERON TL® | 5.12 | ADV9434PRO® | 0.96 | 6.79 | P1630Hx® | 0.80 | 5.70 |
10 | P2530 | 5.00 | P2530 | 0.93 | 6.62 | 2A106 | 0.78 | 5.52 |
11 | ADV9434PRO® | 4.96 | 2A106 | 0.91 | 6.50 | ADV9434PRO® | 0.76 | 5.37 |
12 | P1630Hx® | 4.95 | P3646Hx® | 0.84 | 5.97 | CELERON TL® | 0.74 | 5.26 |
13 | P3646Hx® | 4.36 | P1630Hx® | 0.84 | 5.97 | P3646Hx® | 0.69 | 4.90 |
14 | DEFENDER VIP® | 3.36 | MAXIMUS VIP3® | 0.73 | 5.16 | DEFENDER VIP® | 0.45 | 3.23 |
15 | MAXIMUS VIP3® | 2.72 | DEFENDER VIP® | 0.69 | 4.87 | MAXIMUS VIP3® | 0.39 | 2.77 |
Gain related to the overall mean through HMRPGV*GY (best hybrid): 62% |
|
|